Renal Failure: Clinical Trials

23 trials for Renal Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 terminated, 3 unknown, 2 withdrawn. 23 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 423Completed 12, Terminated 4, Unknown 3, Withdrawn 2, Active not recruiting 1, Recruiting 1

Follow Renal Failure: new trials by email Literature Review of Renal Failure trials Research Report on Renal Failure

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Dapagliflozin (Forxiga®), Placebo matching Dapaglifolzin, Lifestyle Intervention - Type2diabetes, PreDiabetes
Phase 4RecruitingUniversity Hospital Tuebingen1702023-10-262026-09-15
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
Dapagliflozin 10mg Tab, Placebo - Kidney Transplant; Complications, Kidney Transplant Failure
Phase 4Active not recruitingOslo University Hospital3302023-05-022026-10-20
Desflurane vs. Sevoflurane in Endovascular Aortic Repair
Sevoflurane, Desflurane - Renal Failure
Phase 4CompletedBegoña Quintana Villamandos802017-09-202023-11-21
Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination) - Renal Failure
Phase 4CompletedMassachusetts General Hospital82017-02-012020-06-09
Artegraft Versus Propaten Dialysis Grafts
Artegraft, Propaten - ESRD, Renal Failure
Phase 4TerminatedKaiser Permanente12014-04-012019-05-15
Protocolized Diuretic Strategy in Cardiorenal Failure
Protocolized Diuretic Strategy - Cardiac Failure, Renal Failure
Phase 4TerminatedKelly V. Liang, MD192013-11-012017-08-21
The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas
GTN patch, placebo comparator - Renal Failure
Phase 4CompletedUniversity Hospital Birmingham2002013-04-012015-06-02
Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
pharmacokinetic monitoring - Renal Failure
Phase 4WithdrawnMidwestern University2012-01-012018-03-20
Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis
a pre-heparin-coated hemodialysis filter; Hepran - Renal Failure
Phase 4CompletedOslo University Hospital122011-09-012016-02-04
Effects of Spironolactone in Dialysis
Spironolactone - Renal Failure
Phase 4UnknownUPECLIN HC FM Botucatu Unesp602011-03-012011-09-05
The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition
double-chamber bag Stay-Safe Balance system, glucose-based dialysis solution - Renal Failure, ESRD
Phase 4CompletedChinese University of Hong Kong682010-09-012014-09-08
The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
Carperitide heart failure therapy, Standard heart failure therapy - Heart Failure, Renal Failure
Phase 4TerminatedNara Medical University2002009-05-012011-07-22
Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation
albumin, Midodrine, Placebo - Renal Failure, Hyponatremia
Phase 4CompletedHospital Clinic of Barcelona1992008-08-012016-08-18
Rifaximin Versus Lactulose in Renal Failure
Rifaximin, Lactulose - Liver Cirrhosis, Renal Failure
Phase 4WithdrawnWeill Medical College of Cornell University2008-06-012022-02-08
The Vienna Prograf and Endothelial Progenitor Cell Extension Study
Tacrolimus - Immunosuppression, Renal Failure
Phase 4CompletedMedical University of Vienna872008-03-012018-11-23
Inspiratory Muscle Training in Patients With End Stage Renal Failure
Inspiratory muscle training (URES HS730), Sham inspiratory muscle training (URES HS730) - Renal Failure, Chronic Renal Insufficiency
Phase 4UnknownThe University of Queensland482007-12-012011-05-04
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP
Hydratation according LVEDP + NaHCO3, normal saline, Sodium bicarbonate - Radiographic Contrast Agent Nephropathy, Renal Failure
Phase 4UnknownUniversité de Sherbrooke3302007-11-012015-02-12
Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome
dose adaptation of Enoxaparin, normal injection of Enoxaparine - Acute Coronary Syndrome, Renal Failure
Phase 4CompletedFrench Cardiology Society672006-12-012011-07-21
Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
Hectorol (doxercalciferol capsules), 0.5mcg - Secondary Hyperparathyroidism, Renal Failure
Phase 4CompletedGenzyme, a Sanofi Company702005-07-012015-05-05
Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation
mycophenolate mofetil, placebo medication - End-stage Liver Disease, Renal Insufficiency
Phase 4TerminatedBaylor College of Medicine132004-11-012020-03-13

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Renal Insufficiency (23)  ·  Renal Insufficiency, Chronic (3)  ·  Fibrosis (2)  ·  Heart Failure (2)  ·  Kidney Failure, Chronic (2)  ·  Acute Coronary Syndrome (1)  ·  Arteriovenous Fistula (1)  ·  Cardio-Renal Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Nephropathies (1)  ·  Edema (1)  ·  End Stage Liver Disease (1)  ·  Essential Hypertension (1)

Broader conditions

Female Urogenital Diseases (23)  ·  Female Urogenital Diseases and Pregnancy Complications (23)  ·  Male Urogenital Diseases (23)  ·  Urogenital Diseases (23)  ·  Urologic Diseases (23)  ·  Kidney Diseases (22)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Cardiovascular Diseases (7)  ·  Pathologic Processes (7)  ·  Chronic Disease (5)  ·  Disease Attributes (5)  ·  Vascular Diseases (5)  ·  Heart Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Digestive System Diseases (3)

Interventions

dapagliflozin (2)  ·  1 alpha-hydroxyergocalciferol (1)  ·  Acetylcysteine (1)  ·  Albumins (1)  ·  Ceftazidime (1)  ·  Desflurane (1)  ·  Exercise (1)  ·  Lactulose (1)  ·  Midodrine (1)  ·  Mycophenolic Acid (1)  ·  Rifaximin (1)  ·  Saline Solution (1)  ·  Sevoflurane (1)  ·  Sodium Bicarbonate (1)  ·  Spironolactone (1)

Sponsors

Oslo University Hospital (2)  ·  Baylor College of Medicine (1)  ·  Begoña Quintana Villamandos (1)  ·  Chinese University of Hong Kong (1)  ·  French Cardiology Society (1)  ·  Genzyme, a Sanofi Company (1)  ·  Heidelberg University (1)  ·  Hospital Clinic of Barcelona (1)  ·  Kaiser Permanente (1)  ·  Kelly V. Liang, MD (1)  ·  Massachusetts General Hospital (1)  ·  Medical University of Vienna (1)  ·  Midwestern University (1)  ·  Nara Medical University (1)  ·  Technical University of Munich (1)

Countries

United States (7)  ·  Germany (3)  ·  Japan (2)  ·  Norway (2)  ·  Spain (2)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Hong Kong (1)  ·  Puerto Rico (1)  ·  United Kingdom (1)

Top investigators

Cheuk Chun Szeto, MD (1)  ·  Earl Schuman, MD (1)  ·  Gen Yasuda, MD (1)  ·  Gere Sunder-Plassmann, MD (1)  ·  Jennifer D Paratz, PhD (1)  ·  John Goss, MD (1)  ·  Kelly V Liang, MD (1)  ·  Luis C Martin, Doctor (1)  ·  Marc H Scheetz, PharmD (1)  ·  Michel Nguyen, MD, FRCPC (1)  ·  Nicholas G Inston, FRCS (1)

Results publications

PMID 24866870, PMID 26116627, PMID 26510186, PMID 27122492, PMID 27470183, PMID 30138685, PMID 31266056, PMID 33586138, PMID 41079741, PMID 42315275